APA

Uminski K., Brown K., Bucher O., Hibbert I., Dhaliwal D. H., Johnston J. B., Geirnaert M., Dawe D. E. & Banerji V. (20200930). Descriptive analysis of dosing and outcomes for patients with ibrutinib-treated relapsed or refractory chronic lymphocytic leukemia in a Canadian centre. : Current oncology (Toronto, Ont.).

Chicago

Uminski K, Brown K, Bucher O, Hibbert I, Dhaliwal D H, Johnston J B, Geirnaert M, Dawe D E and Banerji V. 20200930. Descriptive analysis of dosing and outcomes for patients with ibrutinib-treated relapsed or refractory chronic lymphocytic leukemia in a Canadian centre. : Current oncology (Toronto, Ont.).

Harvard

Uminski K., Brown K., Bucher O., Hibbert I., Dhaliwal D. H., Johnston J. B., Geirnaert M., Dawe D. E. and Banerji V. (20200930). Descriptive analysis of dosing and outcomes for patients with ibrutinib-treated relapsed or refractory chronic lymphocytic leukemia in a Canadian centre. : Current oncology (Toronto, Ont.).

MLA

Uminski K, Brown K, Bucher O, Hibbert I, Dhaliwal D H, Johnston J B, Geirnaert M, Dawe D E and Banerji V. Descriptive analysis of dosing and outcomes for patients with ibrutinib-treated relapsed or refractory chronic lymphocytic leukemia in a Canadian centre. : Current oncology (Toronto, Ont.). 20200930.